search button

A novel hysteroscopic approach for ovarian cancer screening/early diagnosis (Review)

  • Authors:
    • Salvatore Gizzo
    • Marco Noventa
    • Michela Quaranta
    • Amerigo Vitagliano
    • Carlo Saccardi
    • Pietro Litta
    • Donato Antona

  • View Affiliations

  • Published online on: December 14, 2016     https://doi.org/10.3892/ol.2016.5493
  • Pages: 549-553
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The lethality of epithelial ovarian cancer (EOC) may be due to common misconceptions regarding etiology and the absence of effective screening and early diagnostic tools. Reviews of histopathological surveys performed on the resected fallopian tubes of breast cancer (BRCA) mutation carriers, who underwent risk‑reducing salpingo‑oophorectomy, unexpectedly revealed the presence of occult carcinomas of the fallopian tubes. This finding prompted studies that demonstrated the most accredited theory of type II EOC development, which suggests that a large proportion of these tumors are derived from the fallopian tube. At present, no diagnostic tools or screening programs have been demonstrated to be effective or cost‑effective in improving the outcome of EOC; it is therefore imperative that the scientific community unite its efforts in the identification of a valid screening and/or early diagnostic method for the treatment of this lethal gynecological malignancy. To this end, the present paper proposes a novel tool for the screening/early diagnosis of EOC: The ‘Tuba‑check’. This novel approach is based on the possibility of acquiring specimens for tubal lumen cytology via hysteroscopy in a minimally‑invasive outpatient setting. The present study protocol aimed to validate the technical feasibility and oncological accuracy of the proposed approach, commencing with a cohort of patients with an expected increased oncological risk, including BRCA mutation carriers or those with a gene expression profile of ‘BRCA‑ness’. If the data collected by the present study protocol validates this approach, the ‘Tuba‑check’ may, in the near future, be extended for the treatment of all women, therefore reducing the number of victims of epithelial ovarian carcinoma.
View Figures
View References

Related Articles

Journal Cover

February-2017
Volume 13 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Gizzo S, Noventa M, Quaranta M, Vitagliano A, Saccardi C, Litta P and Antona D: A novel hysteroscopic approach for ovarian cancer screening/early diagnosis (Review). Oncol Lett 13: 549-553, 2017.
APA
Gizzo, S., Noventa, M., Quaranta, M., Vitagliano, A., Saccardi, C., Litta, P., & Antona, D. (2017). A novel hysteroscopic approach for ovarian cancer screening/early diagnosis (Review). Oncology Letters, 13, 549-553. https://doi.org/10.3892/ol.2016.5493
MLA
Gizzo, S., Noventa, M., Quaranta, M., Vitagliano, A., Saccardi, C., Litta, P., Antona, D."A novel hysteroscopic approach for ovarian cancer screening/early diagnosis (Review)". Oncology Letters 13.2 (2017): 549-553.
Chicago
Gizzo, S., Noventa, M., Quaranta, M., Vitagliano, A., Saccardi, C., Litta, P., Antona, D."A novel hysteroscopic approach for ovarian cancer screening/early diagnosis (Review)". Oncology Letters 13, no. 2 (2017): 549-553. https://doi.org/10.3892/ol.2016.5493